Iranian clozapine versus leponex
Not Applicable
- Conditions
- schizophrenia.Schizophrenia
- Registration Number
- IRCT201010042935N4
- Lead Sponsor
- Kurdistan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 32
Inclusion Criteria
Inclusion Criteria: diagnosis of Schizophrenia based on DSM IV, chronic Schizophrenia, resistant schizophrenia (no response to two different antipsychotics at past)
Exclusion Criteria
Substance dependence, any serious medical problem, development of agranulocytosis or seizure during treatment with clozapine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of schizophrenia. Timepoint: Baseline and 3 and 6 months after beginnig of the treatmen. Method of measurement: Positive and Negative Syndrome Scale (PANSS).
- Secondary Outcome Measures
Name Time Method